Roivant Sciences
@Roivant
Followers
2K
Following
282
Media
40
Statuses
252
Roivant aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter
Joined November 2014
Graves’ disease, an autoimmune disease, disproportionately impacts women. Learn how Immunovant is applying a patient-focused approach to help advance treatment for people living with this condition: https://t.co/UecNjdjQ1v
#GravesDisease
0
0
1
Graves' Disease causes an overactive thyroid and hyperthyroidism, with symptoms like nervousness, anxiety, and more. See how we strive to meet the complex and variable needs of people with Graves’ disease through our latest research: https://t.co/zHcHW33KMX
#GravesDisease
0
0
2
#NEWS: Along with Priovant Therapeutics, we announced positive results from the Phase 3 VALOR study evaluating our inflammatory disease prospect in dermatomyositis (DM). Learn more about this exciting moment for the DM community: https://t.co/ypykGI8cxP
0
0
1
This morning, Roivant and Priovant announced positive Phase 3 VALOR study results for brepocitinib in dermatomyositis - find the press release with more details here
investor.roivant.com
Once-daily oral brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all nine key secondary endpoints,...
0
0
2
We’re thrilled to be recognized as a 2025 Best Workplace in BioPharma™. This recognition demonstrates Roivant’s commitment to building a high-performance and talent-oriented culture. Learn about this achievement: https://t.co/uaMpVhJ4Dl #BestWorkplaces #GPTWCertified
greatplacetowork.com
Our Best Workplaces lists highlight organizations excelling in creating positive, inclusive, and engaging environments. Explore top companies recognized for exceptional workplace culture and employee...
0
0
0
✔️Of the 17 responders to therapy, ~50% (8/17) achieved anti-thyroid drug (ATD) free remission at six months following end of batoclimab treatment
1
0
0
✔️Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less than the upper limit of normal) at the end of the six-month follow-up period
1
0
0
✔️First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients
1
0
0
Today we shared remission data from Immunovant's Graves' disesase POC study -- published in an abstract to be presented at the 2025 Annual Meeting of the American Thyroid Association (ATA) on September 11, 2025. See below for more details
1
0
2
Tune into Roivant Q1 earnings happening Monday AM - details below https://t.co/g5384dH5MP
investor.roivant.com
BASEL, Switzerland and LONDON and NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday,...
1
0
1
Off-Target Effects Episode #4 with @gline and Philip Ross @Jefferies on @BiotechTV - catch the podcast on Apple + Spotify 👇
1
0
2
Episode #4 of Off-Target Effects is out! Our CEO and show host @gline interviews Philip Ross from @jefferies to talk about the @blueprintmeds deal with @sanofi, the future of M&A, and Philip’s recent career move. Find it all below on @biotechtv
𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: @gline speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join @Jefferies last year. Full video: https://t.co/MEsmEEcgsj
0
0
7
Don't miss it: New episode of Off-Target Effects with @gline and guest Phil Ross of Jefferies dropping tomorrow on @BiotechTV. Watch the teaser below ⬇️⬇️⬇️
𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: On the next episode of Off-Target Effects, @gline will discuss the M&A environment (and more) with one of the most experienced bankers in biotech, Philip Ross, Chairman of Global Healthcare at Jefferies. Tune in tomorrow! https://t.co/QmH9QsyQZu
0
1
4
Heads up! You can also catch the latest episode of Off-Target Effects with @gline and @adamfeuerstein on Spotify and Apple. Links below ⬇️
1
0
1